January 15, 2020
Dalton Pharma Services, has received a three-year renewal and license amendment of its Cannabis Act Processing License from Health Canada.
January 14, 2020
CBD’s anti-inflammatory properties could make this cannabinoid a viable treatment for heart inflammation concerns.
December 18, 2019
Cardiol Therapeutics Inc. is pleased to announce that it has appointed Michael J. Willner, Esq. as Business Advisor to the...
December 12, 2019
The Investing News Network offers a closer look at 2019's top Canadian cannabis stocks on the TSX, TSXV and CSE.
December 3, 2019
Cardiol Therapeutics Inc. is pleased to announce the appointment of Mr. Colin Stott to its Board of Directors, effective immediately.
November 27, 2019
Diligent CBD testing and oversight could be the key to sustained industry growth and consumer health in North American cannabis.
November 25, 2019
Cardiol Therapeutics Inc. commented on Purisys, LLC's news release issued on November 21st.